Literature DB >> 20571049

Hepatocytes lacking thioredoxin reductase 1 have normal replicative potential during development and regeneration.

MaryClare F Rollins1, Dana M van der Heide, Carla M Weisend, Jean A Kundert, Kristin M Comstock, Elena S Suvorova, Mario R Capecchi, Gary F Merrill, Edward E Schmidt.   

Abstract

Cells require ribonucleotide reductase (RNR) activity for DNA replication. In bacteria, electrons can flow from NADPH to RNR by either a thioredoxin-reductase- or a glutathione-reductase-dependent route. Yeast and plants artificially lacking thioredoxin reductases exhibit a slow-growth phenotype, suggesting glutathione-reductase-dependent routes are poor at supporting DNA replication in these organisms. We have studied proliferation of thioredoxin-reductase-1 (Txnrd1)-deficient hepatocytes in mice. During development and regeneration, normal mice and mice having Txnrd1-deficient hepatocytes exhibited similar liver growth rates. Proportions of hepatocytes that immunostained for PCNA, phosphohistone H3 or incorporated BrdU were also similar, indicating livers of either genotype had similar levels of proliferative, S and M phase hepatocytes, respectively. Replication was blocked by hydroxyurea, confirming that RNR activity was required by Txnrd1-deficient hepatocytes. Regenerative thymidine incorporation was similar in normal and Txnrd1-deficient livers, further indicating that DNA synthesis was unaffected. Using genetic chimeras in which a fluorescently marked subset of hepatocytes was Txnrd1-deficient while others were not, we found that the multigenerational contributions of both hepatocyte types to development and to liver regeneration were indistinguishable. We conclude that, in mouse hepatocytes, a Txnrd1-independent route for the supply of electrons to RNR can fully support DNA replication and normal proliferative growth.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20571049      PMCID: PMC2894656          DOI: 10.1242/jcs.068106

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  74 in total

1.  Thioredoxin reductase 1 deficiency reverses tumor phenotype and tumorigenicity of lung carcinoma cells.

Authors:  Min-Hyuk Yoo; Xue-Ming Xu; Bradley A Carlson; Vadim N Gladyshev; Dolph L Hatfield
Journal:  J Biol Chem       Date:  2006-03-25       Impact factor: 5.157

2.  Thioredoxin is required for deoxyribonucleotide pool maintenance during S phase.

Authors:  Ahmet Koc; Christopher K Mathews; Linda J Wheeler; Michael K Gross; Gary F Merrill
Journal:  J Biol Chem       Date:  2006-03-29       Impact factor: 5.157

3.  Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase.

Authors:  Valentina Gandin; Aristi Potamitou Fernandes; Maria Pia Rigobello; Barbara Dani; Francesca Sorrentino; Francesco Tisato; Mikael Björnstedt; Alberto Bindoli; Alberto Sturaro; Rocco Rella; Cristina Marzano
Journal:  Biochem Pharmacol       Date:  2009-08-07       Impact factor: 5.858

4.  Cre activity in fetal albCre mouse hepatocytes: Utility for developmental studies.

Authors:  Carla M Weisend; Jean A Kundert; Elena S Suvorova; Justin R Prigge; Edward E Schmidt
Journal:  Genesis       Date:  2009-12       Impact factor: 2.487

Review 5.  Thioredoxins and glutaredoxins: unifying elements in redox biology.

Authors:  Yves Meyer; Bob B Buchanan; Florence Vignols; Jean-Philippe Reichheld
Journal:  Annu Rev Genet       Date:  2009       Impact factor: 16.830

Review 6.  Metabolism of selenium compounds catalyzed by the mammalian selenoprotein thioredoxin reductase.

Authors:  Jun Lu; Carsten Berndt; Arne Holmgren
Journal:  Biochim Biophys Acta       Date:  2009-05-03

7.  Treatment of human cancer cells with selenite or tellurite in combination with auranofin enhances cell death due to redox shift.

Authors:  Maria Pia Rigobello; Valentina Gandin; Alessandra Folda; Anna-Klara Rundlöf; Aristi P Fernandes; Alberto Bindoli; Cristina Marzano; Mikael Björnstedt
Journal:  Free Radic Biol Med       Date:  2009-05-29       Impact factor: 7.376

Review 8.  Eukaryotic selenoproteins and selenoproteomes.

Authors:  Alexey V Lobanov; Dolph L Hatfield; Vadim N Gladyshev
Journal:  Biochim Biophys Acta       Date:  2009-05-27

9.  Chemistry, antiproliferative properties, tumor selectivity, and molecular mechanisms of novel gold(III) compounds for cancer treatment: a systematic study.

Authors:  Angela Casini; Gerhard Kelter; Chiara Gabbiani; Maria Agostina Cinellu; Giovanni Minghetti; Dolores Fregona; Heinz-Herbert Fiebig; Luigi Messori
Journal:  J Biol Inorg Chem       Date:  2009-06-20       Impact factor: 3.358

Review 10.  Selenoproteins.

Authors:  Jun Lu; Arne Holmgren
Journal:  J Biol Chem       Date:  2008-08-29       Impact factor: 5.157

View more
  20 in total

1.  Nuclear double-fluorescent reporter for in vivo and ex vivo analyses of biological transitions in mouse nuclei.

Authors:  Justin R Prigge; James A Wiley; Emily A Talago; Elise M Young; Laura L Johns; Jean A Kundert; Katherine M Sonsteng; William P Halford; Mario R Capecchi; Edward E Schmidt
Journal:  Mamm Genome       Date:  2013-09-11       Impact factor: 2.957

2.  Glutathione-glutaredoxin is an efficient electron donor system for mammalian p53R2-R1-dependent ribonucleotide reductase.

Authors:  Rajib Sengupta; Lucia Coppo; Pradeep Mishra; Arne Holmgren
Journal:  J Biol Chem       Date:  2019-07-02       Impact factor: 5.157

Review 3.  The A to Z of modulated cell patterning by mammalian thioredoxin reductases.

Authors:  Markus Dagnell; Edward E Schmidt; Elias S J Arnér
Journal:  Free Radic Biol Med       Date:  2017-12-24       Impact factor: 7.376

Review 4.  Thioredoxin and glutaredoxin-mediated redox regulation of ribonucleotide reductase.

Authors:  Rajib Sengupta; Arne Holmgren
Journal:  World J Biol Chem       Date:  2014-02-26

Review 5.  Thioredoxin and thioredoxin target proteins: from molecular mechanisms to functional significance.

Authors:  Samuel Lee; Soo Min Kim; Richard T Lee
Journal:  Antioxid Redox Signal       Date:  2012-06-26       Impact factor: 8.401

6.  Glutathione and glutaredoxin act as a backup of human thioredoxin reductase 1 to reduce thioredoxin 1 preventing cell death by aurothioglucose.

Authors:  Yatao Du; Huihui Zhang; Jun Lu; Arne Holmgren
Journal:  J Biol Chem       Date:  2012-09-13       Impact factor: 5.157

7.  Hepatocyte DNA replication in growing liver requires either glutathione or a single allele of txnrd1.

Authors:  Justin R Prigge; Sofi Eriksson; Sonya V Iverson; Tesia A Meade; Mario R Capecchi; Elias S J Arnér; Edward E Schmidt
Journal:  Free Radic Biol Med       Date:  2011-12-08       Impact factor: 7.376

8.  A Txnrd1-dependent metabolic switch alters hepatic lipogenesis, glycogen storage, and detoxification.

Authors:  Sonya V Iverson; Sofi Eriksson; Jianqiang Xu; Justin R Prigge; Emily A Talago; Tesia A Meade; Erin S Meade; Mario R Capecchi; Elias S J Arnér; Edward E Schmidt
Journal:  Free Radic Biol Med       Date:  2013-06-03       Impact factor: 7.376

9.  Contributions of new hepatocyte lineages to liver growth, maintenance, and regeneration in mice.

Authors:  Sonya V Iverson; Kristin M Comstock; Jean A Kundert; Edward E Schmidt
Journal:  Hepatology       Date:  2011-06-26       Impact factor: 17.425

10.  Effects of Mammalian Thioredoxin Reductase Inhibitors.

Authors:  Elias S J Arnér
Journal:  Handb Exp Pharmacol       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.